US Stock MarketDetailed Quotes

INSM Insmed

Watchlist
  • 25.810
  • +0.540+2.14%
Close Apr 24 16:00 ET
3.83BMarket Cap-4833P/E (TTM)

About Insmed Company

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolINSM
Company NameInsmed
Listing DateJun 1, 2000
Founded1988
CEOMr. William H. Lewis
MarketNASDAQ
Employees912
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address700 US Highway 202/206
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807-3365
Phone1-908-977-9900
Websitehttp://www.insmed.com

Company Executives

  • Name
  • Position
  • Salary
  • William H. Lewis
  • Chairman of the Board, President and Chief Executive Officer
  • 10.41M
  • Roger Adsett
  • Chief Operating Officer
  • 4.01M
  • Michael A. Smith
  • Chief Legal Officer, Senior Vice President, General Counsel and Secretary
  • --
  • S. Nicole Schaeffer
  • Chief People Strategy Officer
  • 2.31M
  • Dr. Martina Flammer, M.B.A.
  • Chief Medical Officer
  • 4.22M
  • Sara Bonstein
  • Chief Financial Officer and Principal Accounting Officer
  • 4.56M
  • Drayton Wise
  • Chief Commercial Officer
  • 3.89M
  • Dr. Melvin Sharoky,M.D.
  • Independent Director
  • 312.50K
  • Dr. Clarissa Desjardins, PhD
  • Independent Director
  • 315.00K
  • Carol A. Schafer
  • Independent Director
  • 315.00K
  • Leo Lee
  • Independent Director
  • 317.50K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 320.00K
  • David R Brennan
  • Lead Independent Director
  • 345.00K
  • Alfred F. Altomari
  • Independent Director
  • 320.00K
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 310.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg